A randomized, double-blind, controlled clinical study of the Balingfu nutrient regimen for the treatment of menopausal or perimenopausal syndrome.

INTERVENTION: Trial group:Oral Bai Ling Fu nutritional supplement package; Trial group: 3 tablets per time, 2 times daily; duration of treatment is 4 weeks for all participants.;Control group:Oral placebo; Control group: 3 tablets per time, 2 times daily; duration of treatment is 4 weeks for all participants.; CONDITION: Pre‐menopausal/menopausal syndrome PRIMARY OUTCOME: Menopausal symptom score; SECONDARY OUTCOME: Subject satisfaction score;Se Xhormone levels;Vital signs;Menopause‐Specific Quality of Life Score;Adverse Event;Blood routine examination(RBCWBCPLTHb);Liver and kidney function(TB?ALT?AST??‐GT?ALP?SOD?GSSG‐R ?Scr?Bun?UA);Researcher Satisfaction Score;Efficacy of TCM Syndromes; INCLUSION CRITERIA: 1.Aged between 45 and 60 years inclusive; 2.Meeting the diagnostic criteria for menopause/premenopausal syndrome, with a score of >=9 on the Menopause Rating Scale (MRS); 3.Voluntarily participating in this clinical trial, providing informed consent and signing the informed consent form.